TRPC5 and breast cancer: There is evidence that the TRPC5 channel activity increases angiogenesis in cases of breast cancer by the activation of the transcription factor hypoxia-inducible factor 1 (HIF-1), leading to vascular endothelial growth factor (VEGF) formation [114], thereby promoting cancer growth.